Finance

Beta
Lists
ZIM:FRA
Zimmer Biomet Holdings, Inc
€71.80
+1.16%
(+0.82) 1D
Jun 3, 8:02:23 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ZIM...
Open
€71.80
High
€71.80
Low
€71.80
Mkt. cap
16.42B
Avg. vol.
20.00
Volume
0.00
52-wk high
€92.52
52-wk low
€67.36
No. of employees
17K
Open
€71.80
High
€71.80
Low
€71.80
Mkt. cap
16.42B
Avg. vol.
20.00
Volume
0.00
52-wk high
€92.52
52-wk low
€67.36
No. of employees
17K
News stories
From sources across the web
Profile
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
About Zimmer Biomet Holdings, Inc
CEOIvan Tornos
Employees17K
Founded1927
HeadquartersWarsaw, Indiana, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.08B
2.00B
2.24B
2.09B
Cost of goods sold
590.70M
559.30M
795.50M
564.20M
Cost of revenue
590.70M
559.30M
795.50M
564.20M
Research and development expenses
113.30M
115.90M
118.70M
103.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
807.20M
809.40M
838.50M
846.20M
Operating expense
1.08B
1.10B
1.13B
1.11B
Total operating expenses
1.67B
1.66B
1.93B
1.68B
Operating income
405.50M
340.30M
313.40M
410.80M
Other non operating income
3.60M
6.20M
15.10M
5.50M
EBT including unusual items
224.60M
279.20M
97.90M
301.30M
EBT excluding unusual items
327.80M
269.30M
250.00M
340.20M
Income tax expense
71.20M
48.00M
-39.90M
63.00M
Effective tax rate
31.70%
17.19%
-40.76%
20.91%
Other operating expenses
-
-
-
-
Net income
152.80M
230.90M
139.30M
238.10M
Net profit margin
7.36%
11.54%
6.21%
11.41%
Earnings per share
2.07
1.90
2.42
2.09
Interest and investment income
-
-
-
-
Interest expense
-79.30M
-75.40M
-71.90M
-68.80M
Net interest expenses
-79.30M
-75.40M
-71.90M
-68.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
677.30M
623.90M
597.40M
680.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more